Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Stent Implantation Found Preferable for Previously Untreated Non-Complex Coronary Artery Disease

By HospiMedica International staff writers
Posted on 03 Sep 2024

Millions of individuals worldwide undergo percutaneous coronary intervention (PCI) each year, a non-surgical technique to clear blockages in coronary arteries, which supply blood to the heart. More...

Traditionally, coronary artery disease (CAD) is treated using balloon angioplasty, where a deflated balloon on a catheter is guided into a narrowed artery, inflated to open the vessel, and followed by placing a drug-eluting stent (DES) to keep the artery open and reduce the risk of restenosis—the re-narrowing of the artery. While effective, 2% of patients experience in-stent restenosis annually, which can lead to complications due to the stent's permanent presence that can interfere with the artery's natural functions and promote inflammation. This has led to interest in stent-free options like drug-coated balloons (DCB), which have proven as effective as DES in treating small vessel CAD (diameter ≤ 3.0 mm), though questions remain about their long-term efficacy and safety in treating broader coronary artery conditions.

In a surprise finding of the first randomized trial to compare clinical outcomes in previously untreated patients with non-complex disease undergoing PCI, researchers from Xijing Hospital (Xi'an, China) discovered that DCBs did not perform as well as expected against second-generation DES. The RECCAGEFREE I trial, a randomized, non-inferiority trial, enrolled PCI patients with previously untreated, non-complex CAD from 43 sites across China between February 2021 and May 2022. Patients were randomly assigned to either DCB angioplasty with potential rescue stenting (1,133 patients) or to receive a thin-strut sirolimus-eluting stent (1,139 patients). Overall, 9% (106/1,133) of DCB patients required rescue DES placement following unsatisfactory angioplasty results.

At the two-year mark, the primary endpoint—combined rates of cardiac death, target vessel myocardial infarction, and clinically or physiologically necessary target lesion revascularization (Device-Oriented Composite Endpoint [DoCE])—was 6.4% for DCBs and 3.4% for DES, with an absolute risk difference of 3.04%, exceeding the pre-set threshold of 2.68% for non-inferiority. This discrepancy was primarily due to higher rates of revascularization required with DCBs (3.1% vs 1.2%). However, subgroup analysis indicated significant variation in outcomes based on vessel diameter, warranting further research. While DES was preferable for larger vessel disease (diameter > 3.0 mm), in small vessel disease (≤3.0 mm), encompassing over 1,000 patients, DCB and DES showed similar rates of DoCE over two years, highlighting the need for more targeted studies to confirm these findings.

“Drug-coated balloon angioplasty failed to achieve non­inferiority compared to standard treatment with second-generation thin strut drug-eluting stents, mainly due to the need for more repeat procedures (revascularization),” said senior author Dr. Ling Tao from Xijing Hospital. “Our results show that the attempted strategy of “leave nothing behind” by using paclitaxel-coated balloons in de novo non-complex coronary artery disease was disproven, and DES implantation should continue to be the standard of care for these patients.”

Related Links:
Xijing Hospital


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Patient Preoperative Skin Preparation
BD ChloraPrep
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: iStock

Updated Head Injury Guidelines Support Risk-Based CT and Observation Decisions

Head injuries are a common reason for emergency department visits, with most cases classified as mild. However, clinicians must identify patients at risk of intracranial bleeding or other serious injuries... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.